Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by HighteawithIntrepidon May 16, 2018 12:07pm
198 Views
Post# 28039758

Cash

CashMy expectation is that every investment house that follows us has or is
in the process of putting out a post Q1 analysis and they are all going 
to have good things to say about the science and negative opinions
on our lack of cash. So given they are all courting Prometic for the next 
share offering my guess is the rhetoric will have a few pulled punches on 
the lack of cash management. I think the market moved the stock issue 
meter a little closer to 95% than 10%. Hence the down day.
Bullboard Posts